AI Insight
A study by Mass General Brigham researchers found that patients with early Alzheimer's disease show poor adherence to brain health recommendations, including exercise, adequate sleep, hypertension prevention, and heart-healthy diet. Fewer than 3% of studied patients followed all 15 brain health recommendations examined. Adherence rates were similarly low regardless of whether patients pursued treatment with lecanemab, an anti-amyloid antibody medication.
Why it matters
This research highlights a significant gap between available brain health interventions and patient implementation, suggesting that prescribing anti-amyloid medications alone may be insufficient for optimal Alzheimer's care. The findings indicate a need for better support systems to help early Alzheimer's patients adopt lifestyle modifications that could complement medical treatments.
Understand the Science
Researchers at the Mass General Brigham Neuroscience Institute found that most patients with early Alzheimer’s disease are not optimally adhering to recommendations for improving their brain health, including exercising, getting adequate sleep, preventing hypertension and eating a heart-healthy diet. The results, published in The Journal of Prevention of Alzheimer’s Disease, show that fewer than 3% of the studied patients followed all 15 brain health recommendations the researchers examined. Both patients with early Alzheimer’s disease who pursued treatment with lecanemab, an anti-amyloid antibody medication for Alzheimer’s disease, and patients who did not pursue anti-amyloid therapy had poor adherence to brain health recommendations, with no significant difference between the groups.
Source: Early Alzheimer's patients pursuing lecanemab show low adherence to brain health advice